FENC   $5.91  -2.80% Market Closed After Close 5.91 0.0

Fennec Pharmaceuticals Inc
Total Cash 43.05M
totalCashPerShare 1.573
EBITDA
Total Debt 31.79M
quickRatio 7.145
currentRatio 8.023
Total Revenue 48.89M
debtToEquity
Revenue/Share 1.813
ROA 0.08882
ROE
grossProfits
freeCashflow -4.87M
operatingCashflow 23.04M
earningsGrowth
revenueGrowth 1.184
grossMargins 0.95553
ebitdaMargins 0.0
operatingMargins -0.69389
profitMargins 0.05594
enterpriseValue 120.08M
forwardPE 13.378378
floatShares 14.84M
sharesOutstanding 27.36M
sharesShort 1.84M
sharesShortPriorMonth 1.84M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.16%
heldPercentInstitutions 0.53%
Short Ratio help_outline 21.88%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue -0.05
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon 2.73M
trailingEps 0.07%
forwardEps 0.37%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.09 3Q 2024
institutionsCount 97
lastUpdated Nov. 7, 2024, 2:42 a.m.